Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation
- PMID: 18779368
- PMCID: PMC2528569
- DOI: 10.1083/jcb.200806076
Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation
Abstract
C-Met, the receptor of hepatocyte growth factor (HGF), through overexpression or mutation, is a major protooncogene that provides an attractive molecular target for cancer therapy. HGF/c-Met-induced tumorigenesis is dependent, in part, on the transcription factor and oncogene signal transducer and activator of transcription 3 (STAT3), which is believed to be activated by the receptor at the plasma membrane and then to travel to the nucleus where it acts. We demonstrate that although the robust signal to STAT3 elicited from the cytokine oncostatin-M does indeed support this mechanism of STAT3 action, for the weaker STAT3 signal emanating from c-Met, the activated receptor itself needs to be delivered to a perinuclear endosomal compartment to sustain phosphorylated STAT3 in the nucleus. This is signal specific because c-Met-induced extracellular signal-regulated kinase nuclear accumulation does not require receptor trafficking to the perinuclear compartment. This response is triggered from peripheral endosomes. Thus, control of growth factor receptor traffic determines the nature of the signal output, providing novel opportunities for intervention.
Figures





Comment in
-
Survival of the weakest: signaling aided by endosomes.J Cell Biol. 2008 Sep 8;182(5):823-5. doi: 10.1083/jcb.200807165. J Cell Biol. 2008. PMID: 18779366 Free PMC article.
Similar articles
-
HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop.BMC Cancer. 2011 May 19;11:180. doi: 10.1186/1471-2407-11-180. BMC Cancer. 2011. PMID: 21595927 Free PMC article.
-
PKC controls HGF-dependent c-Met traffic, signalling and cell migration.EMBO J. 2004 Oct 1;23(19):3721-34. doi: 10.1038/sj.emboj.7600396. Epub 2004 Sep 23. EMBO J. 2004. PMID: 15385963 Free PMC article.
-
Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.Cancer Res. 2007 May 15;67(10):4869-77. doi: 10.1158/0008-5472.CAN-06-3381. Epub 2007 May 10. Cancer Res. 2007. PMID: 17495323
-
c-Met signalling: spatio-temporal decisions.Cell Cycle. 2005 Mar;4(3):352-5. doi: 10.4161/cc.4.3.1519. Epub 2005 Mar 7. Cell Cycle. 2005. PMID: 15701970 Review.
-
Met receptor dynamics and signalling.Curr Top Microbiol Immunol. 2004;286:21-44. doi: 10.1007/978-3-540-69494-6_2. Curr Top Microbiol Immunol. 2004. PMID: 15645709 Review.
Cited by
-
FCHSD2 controls oncogenic ERK1/2 signaling outcome by regulating endocytic trafficking.PLoS Biol. 2020 Jul 17;18(7):e3000778. doi: 10.1371/journal.pbio.3000778. eCollection 2020 Jul. PLoS Biol. 2020. PMID: 32678845 Free PMC article.
-
PDGFRβ translocates to the nucleus and regulates chromatin remodeling via TATA element-modifying factor 1.J Cell Biol. 2018 May 7;217(5):1701-1717. doi: 10.1083/jcb.201706118. Epub 2018 Mar 15. J Cell Biol. 2018. PMID: 29545370 Free PMC article.
-
Cell signaling by receptor tyrosine kinases.Cell. 2010 Jun 25;141(7):1117-34. doi: 10.1016/j.cell.2010.06.011. Cell. 2010. PMID: 20602996 Free PMC article. Review.
-
A direct role for Met endocytosis in tumorigenesis.Nat Cell Biol. 2011 Jun 5;13(7):827-37. doi: 10.1038/ncb2257. Nat Cell Biol. 2011. PMID: 21642981
-
A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.J Exp Clin Cancer Res. 2019 Feb 19;38(1):89. doi: 10.1186/s13046-019-1091-5. J Exp Clin Cancer Res. 2019. PMID: 30782177 Free PMC article.
References
-
- Birchmeier, C., W. Birchmeier, E. Gherardi, and G.F. Vande Woude. 2003. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4:915–925. - PubMed
-
- Boccaccio, C., M. Ando, L. Tamagnone, A. Bardelli, P. Michieli, C. Battistini, and P.M. Comoglio. 1998. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature. 391:285–288. - PubMed
-
- Christensen, J.G., J. Burrows, and R. Salgia. 2005. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett. 225:1–26. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous